On NRI, IDI, and "Good-Looking" statistics with nothing underneath

Epidemiology

Volumn 25, Issue 2, 2014, Pages 265-267

  Hilden, Jørgen ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; NOTE; RISK ASSESSMENT; STATISTICS;

HUMANS; RISK ASSESSMENT; STATISTICS AS TOPIC;

EID: 84894110203     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0000000000000063     Document Type: Note

References (10)

1. Kerr KF, Wang Z, Janes H, McClelland RL, Psaty BM, Pepe MS. Net Reclassification Indices for evaluating risk prediction instruments: A critical review. Epidemiology. 2014;25:114-121
2. Hlatky MA, Greenland P, Arnett DK, et al; American Heart Association Expert Panel on Subclinical Atherosclerotic Diseases and Emerging Risk Factors and the Stroke Council. Criteria for evaluation of novel markers of cardiovascular risk: A scientific statement from the American Heart Association. Circulation. 2009;119:2408-2416
3. Pepe M, Fang J, Feng Z, Gerds T, Hilden J. The Net Reclassification Index (NRI): A Misleading Measure of Prediction Improvement with Miscalibrated or Overfit Models. UW Biostatistics Working Paper Series. Working Paper 392, 2013. Available at: Biostats.bepress.com/uwbiostat/ paper392. Accessed October 16, 2013
4. Kerr KF, McClelland RL, Brown ER, Lumley T. Evaluating the incremental value of new biomarkers with integrated discrimination improvement. Am J Epidemiol. 2011;174:364-374
5. Hilden J. Preliminary note on: Criteria for Evaluation of Novel Risk Markers of Cardiovascular Risk. A Scientific Statement from the American Heart Associationa (Nov 2009). Available at: Http://staff.pubhealth. ku.dk/~jh/. Accessed 3 October 2013
6. Hilden J, Gerds TA . A note on the evaluation of novel biomarkers: Do not rely on integrated discrimination improvement and net reclassification index. Statist Med. 2013;DOI: 10.1002/sim.5804
7. Hilden J, Gerds T. SMDM Meeting: Abstract, Math Appendices (Oslo, June 2012). Available at: Http://staff.pubhealth.ku.dk/~jh/. Accessed 3 October 2013
8. Greenland S. The need for reorientation toward cost-effective prediction: Comments on Evaluating the added predictive ability of a new marker: From area under the RO C curve to reclassification and beyonda by M. J. Pencina et al., Statistics in Medicine (DOI: 10.1002/sim.2929). Stat Med. 2008;27:199-206
9. Hilden J. The area under the RO C curve and its competitors. Med Decis Making. 1991;11:95-101
10. Hilden J, Habbema DF. Prognosis in medicine: An analysis of its meaning and roles. Theor Med. 1987;8:349-365